Jennifer Peppe
Net Worth
Last updated:
What is Jennifer Peppe net worth?
The estimated net worth of Ms. Jennifer Peppe is at least $11,842,087 as of 3 Jan 2023. She owns shares worth $5,358,612 as insider, has earned $5,442,535 from insider trading and has received compensation worth at least $1,040,940 in Imago BioSciences, Inc..
What is the salary of Jennifer Peppe?
Ms. Jennifer Peppe salary is $346,980 per year as Senior Vice President of Clinical Operations in Imago BioSciences, Inc..
How old is Jennifer Peppe?
Ms. Jennifer Peppe is 54 years old, born in 1971.
What stocks does Jennifer Peppe currently own?
As insider, Ms. Jennifer Peppe owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Imago BioSciences, Inc. (IMGO) | Senior Vice President of Clinical Operations | 148,809 | $36.01 | $5,358,612 |
What does Imago BioSciences, Inc. do?
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Jennifer Peppe insider trading
Imago BioSciences, Inc.
Ms. Jennifer Peppe has made 8 insider trades between 2022-2023, according to the Form 4 filled with the SEC.
The largest trade she's ever made was exercising 119,422 units of IMGO stock on 15 Dec 2022. As of 3 Jan 2023 she still owns at least 148,809 units of IMGO stock.
Imago BioSciences key executives
Imago BioSciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Amy E. Tapper Ph.D. (54) Senior Vice President of Chemistry, Manufacturing & Controls and Non-Clinical Devel.
- Dr. Hugh Young Rienhoff Jr. (72) Chief Executive Officer & Director
- Ms. Jennifer Peppe (54) Senior Vice President of Clinical Operations